Distinct patterns of IL-1α and IL-1β organ distribution - A possible basis for organ mechanisms of innate immunity

Advances in Experimental Medicine and Biology

Volumn 479, Issue , 2000, Pages 185-202

  Hacham, M ^a   Argov, S ^a   White, R M ^a   Segal, S ^a   Apte, R N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; METABOLISM; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; IMMUNITY; INTERLEUKIN-1; LYMPHOID TISSUE; ORGAN SPECIFICITY; PROTEIN ISOFORMS;

ANIMALIA;

EID: 0034475057     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (71)

1. Hepatic sinusoidal endothelium heterogeneity with respect to mannose receptor activity is interleukin-1 dependent
2. Interleukin-6 in biology and medicine
3. Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta
4. Intereukin-1 alpha, interleukin-6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro
5. Activation of neutrophiles by recombinant interleukin-6
6. In vivo biologic and immunohistochemical analysis of Interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia
7. Interleukin-1 beta suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production
8. Detection of interleukin-1 alpha and interleukin-1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays
9. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist
10. Interleukin-1 is an autocrine regulator of human endothelial cell growth
11. IL-1 and its receptor are translocated to the nucleus
12. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells
13. Interleukin-1 and its biologically related cytokines
14. Biologic basis for Interleukin-1 in disease
15. Defective inflammatory response and cytokine synthesis in IL-1β deficient mice
16. Functional role of interleukin-1 beta (IL-1beta) in IL-1beta-converting enzyme-mediated apoptosis
17. Preferential production of interleukin-1 beta over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells
18. Interleukin-1 mediates an alternative pathway for the antiproliferative action of poly(1.C) on human endothelial cells
19. Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute phase response
20. Complementary organ expression of IL-1 vs. IL-6 and CSF-activities in normal and LPS-injected mice
21. IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis
22. Detection of interleukin-1 and interleukin-1 receptor mRNA in human heart by polymerase chain reaction
23. In situ hybridization for the detection of feline interleukin-1 alpha mRNA on the paraffin-embedded section using biotin labeled probes
24. Interleukin-1 is present in normal epidermis
25. Biological and clinical aspects of Interleukin-6
26. Modulation of rat mast cell reactivity by IL-1beta. Divergent effects on nitric oxide and platelet-activating factor release
27. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis
28. Biological activity and receptor binding of human prointerleukin-1β and subpeptides
29. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism
30. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis
31. Expression of interleukin-1 inducible genes and production of IL-1 by aging fibroblasts
32. Cytokine gene expression in the MRL/lpr model of lupus nephritis
33. TNF-alpha and IL-1-alpha induce mannose receptors and apoptosis in glomerular mesangial but not endothelial cells
34. Extension of the life-span of human endothelial cells by an interleukin-1α antisense oligomer
35. Endogenous interleukin-1 alpha must be transported to the nucleus to exert its activity in human endothelial cells
36. Airway epithelium as an effector of inflammation: Molecular regulation of secondary mediators
37. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell mediated cytotoxicity
38. Characterization of type II intracellular IL-1 receptor antagonist (IL-1 ra3); a depot IL-1ra
39. Characterization of intracellular interleukin-1 receptor antagonist II
40. Interleukin-1 beta induces cardiac myocyte growth but inihibits cardiac fibroblast proliferation in culture
41. A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity
42. C-reactive protein protects against pre-erythrocytic stages of malaria
43. Epithelia cells as regulators of airway inflammation
44. The immunobiology of bile and biliary epithelium
45. The role of interleukin-1 in interactive senescence and age-related human endometrial cancer
46. Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor
47. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion
48. Interleukin-6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts
49. Epithelial antibiotics induced at sites of inflammation
50. Human beta-defensin-2
51. Production of beta-defensins by human airway epithelia
52. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
53. Detection of IL-1 alpha and IL-1 beta gene expression by in-situ hybridization: Tissue localization of IL-1 mRNA in the normal C57BL/6 mouse
54. Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis
55. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
56. The expression of cytokines in the organs of normal individuals: A role in homeostasis. A review
57. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawl and by copper/zinc superoxide dismutase down-regulation
58. Fas antigen expression on synovial cells was down-regulated by interleukin-1 beta
59. Endotoxin-induced cytokine gene expression in-vivo. II. Regulation of tumor necrosis factor and interleukin-1 α/β expression and suppression
60. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
61. IL-1beta transduces different signals than IL-1 alpha leading to class II antigen expression on beta-insulinoma RIN-5AH cells through specific receptors
62. Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: Implications in the mechanisms of synergy with camptothecins in vitro and in vivo
63. The IL-1beta-coverting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophiles through activation of IL-1beta
64. Apoptosis and differentiation in the crypt-villus unit of the rat small intestine
65. Identification of a nuclear localization sequence within the structure of the human interleukin-1α precursor
66. C-reactive protein reduces the promotion of human B-cell colony formation by autoreactive T4 cells and T-cell proliferation during the autologous mixed-lymphocyte reaction
67. Stimulation of arachidonic acid metabolism: Differences in potencies of recombinant human interleukin-1α and interleukin-1β on two cell types
68. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
69. Mouse islet cell lysis mediated by interleukin-1 (alpha)-induced Fas
70. Interleukin-1 alpha regulates GI cell cycle progression and arrest in thyroid carcinoma cell lines NIMI and NPA
71. Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice